TABLE 1.

Baseline and postoperative demographic clinical characteristics.

Variable	Pre-DBS	Post-DBS
Gender (female/male)	17/23
Age	61.30 ± 8.97
LEDD (mg)	825.74 ± 421.19	451.25 ± 234.66**
MMSE	27.14 ± 10.32	25.22 ± 3.96
MOCA-B	19.69 ± 5.35	19.44 ± 5.00
PDQ-39	63.20 ± 26.43	45.20 ± 29.74**
GDS	45.06 ± 4.40	45.53 ± 4.51
BDI	17.69 ± 8.78	15.34 ± 9.89
SAS	36.44 ± 6.60	37.35 ± 7.29
SCPA-AUT	16.76 ± 9.09	14.09 ± 8.80
UPDRS-III	43.81 ± 13.18	12.35 ± 6.40**
UPDRS-III temor	4.78 ± 5.16	0.73 ± 1.15**
UPDRS-III rigidity	7.76 ± 4.04	0.89 ± 1.08**
UPDRS-III bradykenisia	17.97 ± 5.56	5.24 ± 3.67**
UPDRS-III PIGD	10.57 ± 3.92	4.43 ± 2.24**

MMSE, Mini-Mental State Exam; MoCA-B, Montreal Cognitive Assessment Basic; SAS, Self Rating Anxiety Scale; BDI, Beck Depression Inventory; GDS, Geriatric Depression Rating Scale; PDQ-39, 39-item Parkinson’s Disease Questionnaire; LEDD, levodopa equivalent dailydose; UPDRS-III, Unified Parkinson’s III total score; SCOPA-AUT, Parkinson’s disease autonomic dysfunction.

**P < 0.01.